Board of Directors
|
Björn C AnderssonBorn in 1946, has been a Board member since 2008 and is Chairman of Medivir’s Audit Committee. He is a Licentiate of Economics and former employee of Handelsbanken, where he was Deputy CEO and Head of Handelsbanken Markets, then Head of Handelsbanken Asset Management. Björn is Chairman of Euroben Life & Pension, Nordben Life, NAXS Nordic Access Buyout Fund AB and a Board member of Bliwa Livförsäkring. |
|
Ingemar KihlströmBorn in 1952. Board member since 2008 and Chairman of Medivir’s Remuneration Committee and a member of its R&D Committee. Ingemar is an Associate Professor at the University of Uppsala, and is a self-employed consultant in the life sciences sector. He possesses broad experience of pharmaceuticals and business development, from the pharmaceutical industry and financial sector. Ingemar previously held senior positions with Pharmacia, Aros Securities and ABG Sundal Collier. He has several directorships in Scandinavia, including chairmanships of Creative Antibiotics AB, Hammercap AB and RecoPharma AB, and is Deputy Chairman of Diagenic ASA. |
||
|
Anna Malm BernstenAnna is also a member of Medivir’s Audit and Remuneration Committees. She was born in 1961, and has been a member of Medivir’s Board since 2006. Anna holds a B.Sc. (Eng.) and possesses broad experience of life sciences. She was previously employed by Medivir, and is a self-employed leadership and business development consultant. Apart from senior executive experience at GE Healthcare Life Sciences, Pharmacia, Assa Abloy, Medivir and Baxter Medical, she was also CEO and President of Carmeda AB. Anna is a Board member of Birdsteep ASA, Cellavision AB, Fagerhult AB, Matrisen AB, Nolato AB and Chairman of Scientific Solutions AB and former Board member of BioPhausia AB. |
|
Göran PetterssonChairman of the Board. He was born in 1945 and elected to Medivir’s Board in 2008. Göran is a pharmacist and market economist (IHM) and possesses long-term experience of the pharmaceutical industry in Sweden and foreign countries. He has been a self-employed life sciences consultant since 2000, and previously held senior positions with the Astra group, KabiVitrum, Pharmacia/PharmaciaUpJohn and Meda. Göran holds several directorships in other companies and is Chairman of OxyPharma AB and Vivoxid Oy and a Board member of Pfizer Sweden’s pension fund and Recipharm AB. |
